Merck's latest Vioxx challenge (clinical trial data);BMS invests in new Swedish HIV treatment

BLOOM (BLOOM), National

Wed 13 Sep 2006 05:25 AM EDT

Recently published reviews from 137 clinical trials show that Vioxx increased risks before 18 months;BMS is investing in a new HIV treatment